Blog Post: Six biomed startups selected to take part in AstraZeneca-Skolkovo accelerator
After a gruelling boot camp and months of preparations, six Russian biomed startups were selected Thursday to take part in the first AstraZeneca-Skolkovo accelerator, in which the companies will get intensive support from the multinational pharma giant for the duration of six months. Edward Krizhanovsky (centre), who took first place in the diagnosis category with his non-invasive glucometer, flanked by Skolkovo's Kirill Kaem and AstraZeneca's medical director for Russia and Eurasia, Kira Blong.Photo... Читать дальше...